Chimeric Antigen Receptor T-Cell Therapy: Background, Toxicities, and Efficacy

carT

CAR-T cell therapy is a new modality of treatment with a unique mechanism of action. The therapy has specific, potentially fatal toxicities. This new therapy requires specialized knowledge to treat these patients in an appropriate manner to prevent further injury and to rapidly administer appropriate therapy.

Total Viewing Time: 53 minutes - 1 video
Instruction Format: Slide and Presentation On Demand Webinar
Cost: Complimentary
Credit: 1 AMA PRA Category 1 Credits™ (Internet Enduring Material)


Published

July 19, 2018

Expires

May 23, 2021

Related Presenters

Shahbaz Malik, MD

Shahbaz Malik, MD

Board certified in Hematology and Medical Oncology